1.25 mg tirzepatide Weight Loss Injections Tirzepatide Weight Loss Injections •

So far, the trials seem to show: high reduction in weight, hovering around 28% for those on a 12-milligram dose self-reported improvements in cardiometabolic risk factors like high blood pressure, insulin, and fasting glucose promising results for type 2 diabetes and fatty liver disease a reduction in pain from knee osteoarthritis Retatrutide may be valuable for those who have had limited success with other weight loss drugs, have a higher BMI, or are at significant metabolic risk

Uses of Tirzepatide Tirzepatide is approved for managing type 2 diabetes

Novo Nordisk have confirmed that the 25 mg pill is equivalent to the 2.4 mg weekly injection, giving a clear dose equivalence starting point

We may pause or hold increases if needed

Gentle stretching for 10-15 minutes twice daily and light walking help maintain muscle flexibility, while avoiding intense exercise during the first month reduces strain on adjusting muscles